Search Within

Aseem Anand

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (11)
  2. Genitourinary Oncology Service (11)
  3. Molecular Pharmacology and Chemistry Program Faculty (11)
  4. Sloan Kettering Institute Faculty (11)
  5. Solid Tumor Oncology Division (11)
  6. GSK Faculty (10)

More Groups

People
  1. Steven Larson (10)
  2. Howard Scher (9)
  3. Daniel Danila (7)
  4. Michael Morris (7)
  5. Glenn Heller (6)
  6. Martin Fleisher (6)

More People

Years
  1. 2025 (1)
  2. 2022 (1)
  3. 2016 (2)
  4. 2015 (1)
  5. 2010 (2)
  6. 2009 (1)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer (1)
  3. Clinical Cancer Research (1)
  4. Clinical Chemistry (1)
  5. Clinical Genitourinary Cancer (1)
  6. EJNMMI Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (2)
  3. American Association for Clinical Chemistry (1)
  4. Elsevier Inc. (1)
  5. Elsevier Science, Inc. (1)
  6. Springer (1)

More Publishers

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A novel predictive model using changes in clinical and serum biomarkers and automated quantitative imaging for mCRPC patients treated with AR-directed therapy
    Meeting Abstract

    Morris, M. J.; Flynn, J.; Zhao, B.; Anand, A.; Sjöstrand, K.; Larson, S. M.; Scher, H. I.; Regazzi, A. M.; Borzillo, G. V.; Park, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Automated bone scan index to optimize prostate cancer working group radiographic progression criteria for men with metastatic castration-resistant prostate cancer
    Journal Article

    Anand, A.; Heller, G.; Fox, J.; Danila, D. C.; Bjartell, A.; Edenbrandt, L.; Larson, S. M.; Scher, H. I.; Morris, M. J.
    Clinical Genitourinary Cancer (2022)

    Fulltext@MSK | Save
  • Automated bone scan index as a quantitative imaging biomarker indicative of efficacy to enzalutamide in patients with metastatic castrate resistant prostate cancer (mCRPC)
    Meeting Abstract

    Anand, A.; Morris, M. J.; Larson, S. M.; Ohlsson, M.; Joseffson, A.; Helgstrand, J. T.; Edenbrandt, L.; Oturai, P. S.; Roeder, M. A.; Bjartell, A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide
    Journal Article

    Anand, A.; Morris, M. J.; Larson, S. M.; Minarik, D.; Josefsson, A.; Helgstrand, J. T.; Oturai, P. S.; Edenbrandt, L.; Røder, M. A.; Bjartell, A.
    EJNMMI Research (2016)

    Fulltext@MSK | Save
  • Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications
    Journal Article

    Rathkopf, D. E.; Larson, S. M.; Anand, A.; Morris, M. J.; Slovin, S. F.; Shaffer, D. R.; Heller, G.; Carver, B.; Rosen, N.; Scher, H. I.
    Cancer (2015)

    Fulltext@MSK | Save
  • Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer
    Journal Article

    Danila, D. C.; Morris, M. J.; de Bono, J. S.; Ryan, C. J.; Denmeade, S. R.; Smith, M. R.; Taplin, M. E.; Bubley, G. J.; Kheoh, T.; Haqq, C.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase 1-2 study
    Journal Article

    Scher, H. I.; Anand, A.; Rathkopf, D.; Shelkey, J.; Morris, M. J.; Danila, D. C.; Larson, S.; Humm, J.; Fleisher, M.; Sawyers, C. L.; more...
    Lancet (2010)

    Fulltext@MSK | Save
  • Circulating prostate tumor cells detected by Reverse transcription-PCR in men with localized or castration-refractory prostate cancer: Concordance with CellSearch assay and association with bone metastases and with survival
    Journal Article

    Helo, P.; Cronin, A. M.; Danila, D. C.; Wenske, S.; Gonzalez-Espinoza, R.; Anand, A.; Koscuiszka, M.; Väänänen, R. M.; Pettersson, K.; Chun, F. K. H.; more...
    Clinical Chemistry (2009)

    Fulltext@MSK | Save
  • Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Leversha, M. A.; Gonzalez-Espinoza, R.; Anand, A.; Gu, B.; Gignac, G. A.; Larson, S.; Heller, G.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Circulating tumor cells as prognostic biomarkers in patients with metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Heller, G.; Leversha, M. A.; Lilja, H.; Gonzalez-Espinoza, R.; Anand, A.; Larson, S.; Schwartz, L. H.; Fleisher, M.; Scher, H. I.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save